BIIB111
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for BIIB111, covering 2023-09-18 to 2026-07-06. Get the full timeline:
Most recent: Clinical Trial Update: Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa [Phase 3]